Creates significant synergy opportunities by combining Mindray's leading China-based R&D and production platform and Datascope's strong US-based
direct sales and service network Provides powerful platform for Mindray's international expansion in United
States and Europe
SHENZHEN, China, March 11 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), today announced a definitive agreement to acquire Datascope Corp.'s (Nasdaq: DSCP) patient monitoring business, creating upon completion the third-largest player in the global patient monitoring device industry and furthering the company's goal of becoming a leading provider of high-quality medical devices to markets worldwide. Datascope's patient monitoring business achieved total revenues of US$161.3 million in calendar year 2007, approximately the same revenues generated from Mindray's home China market. The transaction is expected to be accretive to Mindray's earnings per share on a non-GAAP basis starting in 2009.
Upon closing, Mindray expects to benefit from the synergies created by
combining Mindray's strong China-based engineering and production platforms
with Datascope's established brands, long standing reputation for
high-quality products and service, its large and established direct sales
and service team in the United States and Europe and both companies'
leading R&D capabilities. "This transaction represents a unique combination
of strengths that will help transfor
|SOURCE Mindray Medical International Limited|
Copyright©2008 PR Newswire.
All rights reserved